Featured Research

from universities, journals, and other organizations

Embryos That Implant In Uterus "Late" Prove More Likely To Die In First Weeks Of Pregnancy

Date:
June 11, 1999
Source:
National Institute Of Environmental Health Sciences
Summary:
Researchers at the National Institute of Environmental Health Sciences said today that fertilized human eggs that implant late are less likely to survive.

Researchers at the National Institute of Environmental Health Sciences said today that fertilized human eggs that implant late are less likely to survive.

The road to birth is a perilous one. These same NIEHS scientists showed in 1988 (New England Journal of Medicine, 319, pp 189-94) that 25 percent of fertilized eggs fail to survive six weeks -- so early that most mothers did not know they had been pregnant. Only daily urine testing for shifting traces of a hormone called hCG confirmed these pregnancies and their loss. The 25 percent early loss, when added to the clinical miscarriages that occur later, means that at least one-third of all embryos fail.

Today, the researchers reported they have found that the lost fetuses tend to be those that implant late. (NEJM, June 10.) The implantation of the fertilized egg in the wall of the uterus is necessary for the nourishment and growth of the fetus. Surviving pregnancies implanted only about one day earlier, on average, than the non-survivors: 10.5 days v. 9.1 days from fertilization to implantation. But the day-by-day trend was clear. If a fertilized egg implanted by the ninth day, it had only a 13 percent chance of loss. The risk rose to 26 percent if the implantation was on the tenth day, 52 percent on the eleventh day, and 82 percent thereafter. All three implantations after day 12 ended in early loss. There was no association in the NIEHS study between late implantation and the clinical miscarriages that occurred later in pregnancy.

NIEHS' Allen J. Wilcox, M.D., Ph.D., Donna Baird, Ph.D., and Clarice R. Weinberg, Ph.D., said their study could not determine the mechanisms at work. They speculate that embryos that implant more slowly may be imperfect in some way. Thus, they said, "the uterus may be receptive to pregnancy only during a limited time-window, shutting out defective embryos that get there too late. This would spare a mother the physiologic burden of supporting a non-viable embryo."

The current report is based on the careful testing of daily urine samples from about 200 North Carolina women. This relatively large study in normal, fertile women confirms more tentative data from two small reports in 1991 and 1993.


Story Source:

The above story is based on materials provided by National Institute Of Environmental Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

National Institute Of Environmental Health Sciences. "Embryos That Implant In Uterus "Late" Prove More Likely To Die In First Weeks Of Pregnancy." ScienceDaily. ScienceDaily, 11 June 1999. <www.sciencedaily.com/releases/1999/06/990611074751.htm>.
National Institute Of Environmental Health Sciences. (1999, June 11). Embryos That Implant In Uterus "Late" Prove More Likely To Die In First Weeks Of Pregnancy. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/06/990611074751.htm
National Institute Of Environmental Health Sciences. "Embryos That Implant In Uterus "Late" Prove More Likely To Die In First Weeks Of Pregnancy." ScienceDaily. www.sciencedaily.com/releases/1999/06/990611074751.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins